CYP24A1 and cancer: Since metastasis and recurrence could be correlated to cancer resistance, we calculated and pooled the ORs (odds ratio) of metastasis and recurrence in the CYP24A1 subpopulation to evaluate the effect of CYP24A1 expression on drug resistance.